Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 2, 2009, Pages 205-211

  Kawasaki, Tomohiro ^a   Koga, Hisashi ^a   Serikawa, Takeshi ^a   Orita, Yoshiya ^a   Ikeda, Shinsuke ^a   Mito, Takahiro ^a   Gotou, Yoshitaka ^a   Shintani, Yoshiaki ^a   Tanaka, Atsushi ^a   Tanaka, Hidenori ^a   Fukuyama, Takaya ^a   Koga, Nobuhiko ^a  

^a SHIN KOGA HOSPITAL   (Japan)

Author keywords

Drug eluting stent; Intravascular ultrasound; Stent

Indexed keywords

PACLITAXEL; RAPAMYCIN;

AGED; ARTERY DIAMETER; ARTICLE; ATMOSPHERIC PRESSURE; CALCULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DELAYED IMPLANTATION; DRUG ELUTING STENT; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRESSURE MEASUREMENT; PROLONGED DELIVERY INFLATION TIME; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 60649098358     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21813     Document Type: Article

References (17)

1. Morice MC, Serruys PW, Sousa JE, et al.; for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Eng J Med 2002;346:1773-1780.
2. Stone GW, Ellis SG, Cox DA, et al.; for the TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Eng J Med 2004;350: 221-231.
3. Weisz G, Leon MB, Holmes DR Jr, et al. Two-year outcomes after sirolimus-eluting stent implantation: Results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. J Am Coll Cardiol 2006;47:1350-1355.
4. Hoffmann R, Mintz GS, Mehran R, et al. Intravascular ultrasound predictors of angiographic restenosis in lesions treated with palmaz-schatz stents. J Am Coll Cardiol 1998;31:43-49.
5. Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997; 30:1428-1436.
6. Kasoka S, Tobis JM, Akiyama T, et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 1998;32:1630-1635.
7. Werner GS, Gastmann O, Ferrari M, et al. Risk factors for acute and subacute stent thrombosis after high-pressure stent implantation: A study by intracoronary ultrasound. Am Heart J 1998; 135:300-309.
8. Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the mordan era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103:1967-1971.
9. Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent thrombosis: Result of a systematic intravascular ultrasound study. Circulation 2003;108:43-47.
10. Ako J, Morino Y, Sonoda S, et al. Effect of sirolimus-eluting stent on neointimal hyperplasia: A serial in-stent IVUS interim analysis from the SIRIUS trial. Circulation 2002;106:II-520.
11. Sonoda S, Morino Y, Ako J, et al.; SIRIUS investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: Serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol 2004;43:1959-1963.
12. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2005;45:995-998.
13. Stone GW, St. Goar FG, Hodgson JM, et al. Analysis of the relation between stent implantation pressure and expansion. Am J Cardiol 1999;83:1397-1400.
14. Maddux JT, Crroll JD, Groves BM, et al. Optimal deployment of third-generation stents: An intravascular ultrasound assessment. Catheter Cardiovasc Interv 2002;57:142-147.
15. Hoffmann R, Haager P, Mintz GS, et al. The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial. Eur Heart J 2001;22:2015-2024.
16. Cheneau E, Satler LF, Escolar E, et al. Underexpansion of sirolimus-eluting stent: Incidence and relationship to delivery pressure. Catheter Cardiovasc Interv 2005;65:222-226.
17. Javaid A, Chu WW, Cheneau E, et al. Comparison of paclitaxel-eluting stent expansion at incremental delivery pressures. Cardiovasc Revasc Med 2006;7:208-211.